Label: PANAKARE PLUS- pancreatic enzyme tablet

  • NDC Code(s): 59051-9067-5, 59051-9067-7
  • Packager: Neogen Corporation-Mercer
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 23, 2024

If you are a consumer or patient please visit this version.

View All Sections

  • PanaKare Plus Tablets

    Pancreatic Enzyme Concentrate

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • USE IN SPECIFIC POPULATIONS

    FOR ANIMAL USE ONLY

  • COMPONENTS

    Each tablet contains a minimum of:

    Lipase..............................9,000 USP units

    Protease.........................57,000 USP units

    Amylase..........................64,000 USP units

  • Description:

    PanaKare Plus is a pancreatic enzyme concentrate of porcine origin.

  • Precautions:

    Discontinue use in animals with symptoms of sensitivity or allergy.

  • SPL UNCLASSIFIED SECTION

    Made in the USA of U.S. and imported materials

  • WARNINGS

    KEEP OUT OF REACH OF CHILDREN

  • INDICATIONS & USAGE

    Indications:

    As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

    Directions for use:

    Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

    Average dose/meal:

    Dogs: 2-3 tablets

    Cats: 1/2-1 tablet

  • STORAGE AND HANDLING

    Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).

  • SPL UNCLASSIFIED SECTION

    Manufactured by: Neogen Corporation

    Lexington, KY 40511 859-254-1221

    neogen.com

  • PRINCIPAL DISPLAY PANEL - 500 Tablet Bottle

    NDC: 59051-9067-7

    PanaKare Plus Tablets

    Pancreatic Enzyme Concentrate

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Net Contents: 500 Tablets

    PanaKare Plus Tablets 500ct

  • PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle

    NDC: 59051-9067-5

    PanaKare Plus Tablets

    Pancreatic Enzyme Concentrate

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Net Contents: 100 Tablets

    PanaKare Plus Tablets 100ct

  • INGREDIENTS AND APPEARANCE
    PANAKARE PLUS 
    pancreatic enzyme tablet
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:59051-9067
    Route of AdministrationOral
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PANCRELIPASE LIPASE (UNII: 8MYC33932O) (PANCRELIPASE LIPASE - UNII:8MYC33932O) PANCRELIPASE LIPASE9000 [iU]
    PANCRELIPASE AMYLASE (UNII: YOJ58O116E) (PANCRELIPASE AMYLASE - UNII:YOJ58O116E) PANCRELIPASE AMYLASE64000 [iU]
    PANCRELIPASE PROTEASE (UNII: 3560D81V50) (PANCRELIPASE PROTEASE - UNII:3560D81V50) PANCRELIPASE PROTEASE57000 [iU]
    Product Characteristics
    ColorbrownScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59051-9067-7500 in 1 BOTTLE, PLASTIC
    2NDC:59051-9067-5100 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/15/2013
    Labeler - Neogen Corporation-Mercer (042125879)
    Establishment
    NameAddressID/FEIBusiness Operations
    Neogen Corporation-Mercer042125879analysis, label, manufacture
    Establishment
    NameAddressID/FEIBusiness Operations
    ALI Pharmaceutical Manufacturing, LLC080861914api manufacture
    Establishment
    NameAddressID/FEIBusiness Operations
    Scientific Protein Laboratories LLC065240319api manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events (Animal Drug), FDA Safety Recalls (Animal Drug)

Related Resources

Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!